Shilpa Medicare's NorUDCA Makes History as First Approved NAFLD Therapy Worldwide

Aug 14, 2025

Raichur (Karnataka) [India], August 14: In a landmark moment for global hepatology and Indian pharmaceutical innovation, Shilpa Medicare Limited (BSE: 530661) (NSE: SHILPAMED) has...

Health Ministry organizes webinar for medical officers of PHCs, district hospitals

Jun 08, 2023

The Union Ministry of Health and Family Welfare on Thursday organized a webinar on Non-Alcoholic Fatty Liver Diseases (NAFLD) to empower medical officers of...

Disruption In India's Wellness Market: dLife Introduces 'Reverse Or Refund' Guarantee For Type 2 Diabetes, PCOS & NAFLD

Mar 06, 2026

New Delhi [India], March 6: India's chronic lifestyle disease management playbook has traditionally focused on lifelong management through medicines and medical procedures. Patients are...

How Metabolic Surgery Reverses Multiple Health Problems Like Type 2 diabetes, PCOD, obstructive sleep apnea, infertility and NAFLD

May 26, 2026

New Delhi [India], May 26: In today's medical science, one of the most advanced and effective processes to treat health problems like Type 2...

Centre launches operational guidelines for critical illnesses including cancer, diabetes

Feb 22, 2021

New Delhi [India], February 22 : Union Minister of Health and Family Welfare Dr Harsh Vardhan launched the operational guidelines for Integration of NAFLD...

Shilpa Medicare Secures SEC-CDSCO Nod for Nor-Ursodeoxycholic Acid Tablets, Eyes Market Launch for NASH

Mar 12, 2025

Raichur (Karnataka) [India], March 12: Shilpa Medicare Limited (BSE: 530549) (NSE: SHILPAMED), a leading API and formulation manufacturer, announces that the Subject Expert Committee...